BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23942221)

  • 1. Differential receipt of sentinel lymph node biopsy within practice-based research networks.
    Meyer AM; Reeder-Hayes KE; Liu H; Wheeler SB; Penn D; Weiner BJ; Carpenter WR
    Med Care; 2013 Sep; 51(9):812-8. PubMed ID: 23942221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation.
    Carpenter WR; Reeder-Hayes K; Bainbridge J; Meyer AM; Amos KD; Weiner BJ; Godley PA
    Med Care; 2011 Feb; 49(2):172-9. PubMed ID: 21206296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer.
    Reeder-Hayes KE; Bainbridge J; Meyer AM; Amos KD; Weiner BJ; Godley PA; Carpenter WR
    Breast Cancer Res Treat; 2011 Aug; 128(3):863-71. PubMed ID: 21340480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Mann JM; Wu X; Christos P; Nagar H
    Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer.
    Yen TWF; Li J; Sparapani RA; Laud PW; Nattinger AB
    Medicine (Baltimore); 2016 Aug; 95(31):e4392. PubMed ID: 27495053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
    Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation.
    Carpenter WR; Meyer AM; Wu Y; Qaqish B; Sanoff HK; Goldberg RM; Weiner BJ
    Med Care; 2012 Aug; 50(8):737-48. PubMed ID: 22437624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.
    Tan HJ; Meyer AM; Kuo TM; Smith AB; Wheeler SB; Carpenter WR; Nielsen ME
    Cancer; 2015 Mar; 121(6):836-43. PubMed ID: 25410684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
    Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
    JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
    Marrazzo A; Damiano G; Taormina P; Buscemi S; Lo Monte AI; Marrazzo E
    Clin Breast Cancer; 2017 Apr; 17(2):e53-e57. PubMed ID: 27840075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience.
    Quan ML; Hodgson N; Lovrics P; Porter G; Poirier B; Wright FC
    Breast J; 2008; 14(5):421-7. PubMed ID: 18657140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
    Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
    Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer.
    Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V
    Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoption of surgical innovations: factors influencing use of sentinel lymph node biopsy for breast cancer.
    Wright FC; Gagliardi AR; Fraser N; Quan ML
    Surg Innov; 2011 Dec; 18(4):379-86. PubMed ID: 21742665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
    Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
    Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
    Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.